Gene · 825
Papers1,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Population Reference Data in the Molecular Diagnosis of Pathogenic CAPN3 Variants: Contextual Evidence and Interpretive Limits. | Mol Diagn Ther | 2026 | 42782423 | PubTator, text mining | PubMed |
| CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype. | Hum Mol Genet | 2026 | 42725915 | PubTator, text mining | PubMed |
| Reply to: "Autosomal-Dominant Dystonia Associated with CAPN3 Variant". | Mov Disord | 2026 | 42716911 | PubTator, text mining | PubMed |
| Autosomal-Dominant Dystonia Associated with CAPN3 Variant. | Mov Disord | 2026 | 42713740 | PubTator, text mining | PubMed |
| Impaired Myogenic Differentiation Is a Shared Feature Across Genetic Myopathies. | Int J Mol Sci | 2026 | 42511681 | PubTator, text mining | PubMed |
| Withdrawal: Human calpain-3 and its structural plasticity: Dissociation of a homohexamer into dimers on binding titin. | J Biol Chem | 2026 | 42508284 | PubTator, text mining | PubMed |
| Defining Haplosufficiency in Autosomal Recessive Limb-Girdle Muscular Dystrophy Using Molecular Markers in Disease Carriers. | Neurol Genet | 2026 | 42453854 | PubTator, text mining | PubMed |
| Correction of aberrant splicing caused by intronic CAPN3 pathogenic variants using RNA-targeted therapeutic strategies in limb-girdle muscular dystrophy type R1. | Orphanet J Rare Dis | 2026 | 42288923 | PubTator, text mining | PubMed |
| Myoclonus-Dystonia Associated with Heterozygous CAPN3 Splice-Site Variant. | Mov Disord | 2026 | 42237535 | PubTator, text mining | PubMed |
| Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. | Am J Med Genet A | 2026 | 42212615 | PubTator, text mining | PubMed |
| Proteomic insights into azoospermia: protein differences in testicular tissue between non-obstructive and obstructive azoospermia patients. | Asian J Androl | 2026 | 42210639 | PubTator, text mining | PubMed |
| Inflammation-Linked Muscle Atrophy in Limb Girdle Muscular Dystrophy R1 (LGMDR1): Insights into Disease Mechanisms. | Curr Issues Mol Biol | 2026 | 42042021 | PubTator, text mining | PubMed |
| Novel Missense Variants in TRIM37 Associated with Mulibrey Nanism and Complex Congenital Heart Disease. | Cardiol Cardiovasc Med | 2026 | 41907767 | PubTator, text mining | PubMed |
| Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation. | Proc Natl Acad Sci U S A | 2026 | 41871251 | PubTator, text mining | PubMed |
| Mistranslation from an endogenous tRNA variant in human pan-genome cell lines. | Nucleic Acids Res | 2026 | 41841496 | PubTator, text mining | PubMed |
| Protease-mediated PRC1 dissociation promotes H2AK119ub remodeling during stress responses. | EMBO J | 2026 | 41813846 | PubTator, text mining | PubMed |
| Structure-Guided Optimization and Biological Validation of 1,3,4-Thiadiazole-Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions. | Drug Dev Res | 2026 | 41805109 | PubTator, text mining | PubMed |
| Molecular Insights and Orthopedic Management in Muscular Dystrophies: A Comprehensive Review. | Int J Mol Sci | 2026 | 41752033 | PubTator, text mining | PubMed |
| Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing. | Mol Genet Genomic Med | 2026 | 41742649 | PubTator, text mining | PubMed |
| Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis. | Neuropathol Appl Neurobiol | 2026 | 41645489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/825/papers